Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized double-blind trial of esflurbiprofen hydrogel patch in acute limb soft-tissue injuries
2020-005165-14Phase 2Completed
- Sponsor
- Teikoku Seiyaku Co., Ltd.
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Soft tissue injury of extremity (STI), Ankle sprain, Contusion of limb and 2 more comparing Esflurbiprofen hydrogel patch with Placebo patch (2 arms). Started Jan 2021; status: completed.
02
Drugs
esflurbiprofen
03
Conditions
Soft tissue injury of extremity (STI)Ankle sprainContusion of limbmuscle strainExtremity ligament sprain
Beyond the preview
Go deeper on 2020-005165-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-005165-14.